PHARMACEUTICAL FORMULATIONS COMPRISING OPIOID RECEPTOR AGONIST AS ACTIVE INGREDIENTS, METHODS OF MANUFACTURE AND THERAPEUTIC USES THEREOF
The present invention concerns a pharmaceutical formulation in form of aqueous solution for sublingual and buccal administration, for the treatment of neonatal abstinence syndrome, said formulation comprising buprenorphine or a pharmaceutically acceptable salt thereof as the sole active ingredient,...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CAIVANO GRAZIA SILVA BORGES ANA FILIPA |
| description | The present invention concerns a pharmaceutical formulation in form of aqueous solution for sublingual and buccal administration, for the treatment of neonatal abstinence syndrome, said formulation comprising buprenorphine or a pharmaceutically acceptable salt thereof as the sole active ingredient, a viscosity enhancer, and a buffering agent in an amount to provide a pH of from 5.0 to 7.0.
本发明涉及用于舌下和含服施用的呈水溶液形式的药物制剂，其用于治疗新生儿戒断综合征，所述制剂包含丁丙诺啡或其药学上可接受的盐作为唯一活性成分、粘度增强剂和提供5.0-7.0的pH的量的缓冲剂。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN111246841A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN111246841A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN111246841A3</originalsourceid><addsrcrecordid>eNqNzTEKAjEQheFtLES9w9hrsSpiO2Qn7sAmE5KJ7bJIrEQFvYS3VhYPYPXg54M3rd6hxejQUFY22IGV6HKHyuITGHEhcmJ_BAks3EAkQ0ElAh7Fc1LABGiUTwRfFalh8ppW4EhbaRKIBYc-26_JkQB9A9pSxDD-QU6UxkBi59XkMlyfZfHbWbW0pKZdl8e9L8_HcC638uqNr-t6s9sfdjVu_zEf-SM_IA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL FORMULATIONS COMPRISING OPIOID RECEPTOR AGONIST AS ACTIVE INGREDIENTS, METHODS OF MANUFACTURE AND THERAPEUTIC USES THEREOF</title><source>esp@cenet</source><creator>CAIVANO GRAZIA ; SILVA BORGES ANA FILIPA</creator><creatorcontrib>CAIVANO GRAZIA ; SILVA BORGES ANA FILIPA</creatorcontrib><description>The present invention concerns a pharmaceutical formulation in form of aqueous solution for sublingual and buccal administration, for the treatment of neonatal abstinence syndrome, said formulation comprising buprenorphine or a pharmaceutically acceptable salt thereof as the sole active ingredient, a viscosity enhancer, and a buffering agent in an amount to provide a pH of from 5.0 to 7.0.
本发明涉及用于舌下和含服施用的呈水溶液形式的药物制剂，其用于治疗新生儿戒断综合征，所述制剂包含丁丙诺啡或其药学上可接受的盐作为唯一活性成分、粘度增强剂和提供5.0-7.0的pH的量的缓冲剂。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200605&DB=EPODOC&CC=CN&NR=111246841A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200605&DB=EPODOC&CC=CN&NR=111246841A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CAIVANO GRAZIA</creatorcontrib><creatorcontrib>SILVA BORGES ANA FILIPA</creatorcontrib><title>PHARMACEUTICAL FORMULATIONS COMPRISING OPIOID RECEPTOR AGONIST AS ACTIVE INGREDIENTS, METHODS OF MANUFACTURE AND THERAPEUTIC USES THEREOF</title><description>The present invention concerns a pharmaceutical formulation in form of aqueous solution for sublingual and buccal administration, for the treatment of neonatal abstinence syndrome, said formulation comprising buprenorphine or a pharmaceutically acceptable salt thereof as the sole active ingredient, a viscosity enhancer, and a buffering agent in an amount to provide a pH of from 5.0 to 7.0.
本发明涉及用于舌下和含服施用的呈水溶液形式的药物制剂，其用于治疗新生儿戒断综合征，所述制剂包含丁丙诺啡或其药学上可接受的盐作为唯一活性成分、粘度增强剂和提供5.0-7.0的pH的量的缓冲剂。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzTEKAjEQheFtLES9w9hrsSpiO2Qn7sAmE5KJ7bJIrEQFvYS3VhYPYPXg54M3rd6hxejQUFY22IGV6HKHyuITGHEhcmJ_BAks3EAkQ0ElAh7Fc1LABGiUTwRfFalh8ppW4EhbaRKIBYc-26_JkQB9A9pSxDD-QU6UxkBi59XkMlyfZfHbWbW0pKZdl8e9L8_HcC638uqNr-t6s9sfdjVu_zEf-SM_IA</recordid><startdate>20200605</startdate><enddate>20200605</enddate><creator>CAIVANO GRAZIA</creator><creator>SILVA BORGES ANA FILIPA</creator><scope>EVB</scope></search><sort><creationdate>20200605</creationdate><title>PHARMACEUTICAL FORMULATIONS COMPRISING OPIOID RECEPTOR AGONIST AS ACTIVE INGREDIENTS, METHODS OF MANUFACTURE AND THERAPEUTIC USES THEREOF</title><author>CAIVANO GRAZIA ; SILVA BORGES ANA FILIPA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN111246841A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>CAIVANO GRAZIA</creatorcontrib><creatorcontrib>SILVA BORGES ANA FILIPA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CAIVANO GRAZIA</au><au>SILVA BORGES ANA FILIPA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL FORMULATIONS COMPRISING OPIOID RECEPTOR AGONIST AS ACTIVE INGREDIENTS, METHODS OF MANUFACTURE AND THERAPEUTIC USES THEREOF</title><date>2020-06-05</date><risdate>2020</risdate><abstract>The present invention concerns a pharmaceutical formulation in form of aqueous solution for sublingual and buccal administration, for the treatment of neonatal abstinence syndrome, said formulation comprising buprenorphine or a pharmaceutically acceptable salt thereof as the sole active ingredient, a viscosity enhancer, and a buffering agent in an amount to provide a pH of from 5.0 to 7.0.
本发明涉及用于舌下和含服施用的呈水溶液形式的药物制剂，其用于治疗新生儿戒断综合征，所述制剂包含丁丙诺啡或其药学上可接受的盐作为唯一活性成分、粘度增强剂和提供5.0-7.0的pH的量的缓冲剂。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN111246841A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | PHARMACEUTICAL FORMULATIONS COMPRISING OPIOID RECEPTOR AGONIST AS ACTIVE INGREDIENTS, METHODS OF MANUFACTURE AND THERAPEUTIC USES THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T23%3A33%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CAIVANO%20GRAZIA&rft.date=2020-06-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN111246841A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |